G-FACTOR,
WHERE COMPETENCES, CAPITAL AND COMMUNITY TAKE ACTION

LIFE SCIENCE INNOVATION 2020: APPLICATIONS ARE OPEN

9

months of acceleration

34

participating mentors

1.000.000€

IN IINVESTMENTS

8

SELECTED TEAMS

G-FACTOR

G-Factor is a reaction environment, which seeks to transform the potential for technological innovation that lies in young people and in scientists, into entrepreneurial realities able to successfully establish themselves in the market, creating replicable and scalable business models.

It is a response to address the need to integrate scientific research, industry and the market, focusing on young people and their business ideas.

Located in a one-of-a-kind territorial ecosystem with a strong scientific and entrepreneurial history, G-Factor aims to enable new entrepreneurs to grow, with an understanding approach following scientific and market principles, and with the support of personalized incubator and accelerator programs, access to capital, structures, and relationships.

LEGGI TUTTOMOSTRA MENO

Call Life Science - Apply Before 10/31/2019

The call, in its 2nd edition, is aimed at newcos, spinoffs and innovative startups, students, graduates and research doctorates, acting individually or in teams - belonging to public and private entities. Participating teams must have at least one team member under the age of 40.

The projects must be characterized by a strong mission in technology transfer and propose highly innovative therapeutic solutions for which an experimental proof of concept has already been completed in one of the following sectors: pharma, biotech, medtech, bioinformatics and bioengineering.

Roadshow presentazione call

image
GRATUITO
Mercoledì 18 Set 2019 ore 14:30
Terzo appuntamento del roadshow: il team di G-Factor, incubatore e acceleratore di Fondazione Golinelli, presenta la Call Life Science Innovation 2020 a ricercatori, scienziati e docenti dell'Istituto Ortopedico Rizzoli di Bologna. La Call del valore di 1 milione di euro supporterà 8 team, spinoff e startup nei settori pharma e biotech, medtech, nutraceutica, bioinformatica e bioingegneria.
Istituto Ortopedico Rizzoli image

image Evento
image Impresa
GRATUITO
Giovedì 19 Set 2019 ore 11:00
Il roadshow vola a Cagliari: il team di G-Factor, incubatore e acceleratore di Fondazione Golinelli, presenta la Call Life Science Innovation 2020 a ricercatori, scienziati e docenti dell'Università degli Studi di Cagliari. La Call del valore di 1 milione di euro supporterà 8 team, spinoff e startup nei settori pharma e biotech, medtech, nutraceutica, bioinformatica e bioingegneria.
Università degli Studi di Cagliari image

image Evento
image Impresa
GRATUITO
Lunedì 23 Set 2019 ore 14:30
Il roadshow approda in Toscana: il team di G-Factor, incubatore e acceleratore di Fondazione Golinelli, presenta la Call Life Science Innovation 2020 a ricercatori, scienziati e docenti dell'Università di Pisa. La Call del valore di 1 milione di euro supporterà 8 team, spinoff e startup nei settori pharma e biotech, medtech, nutraceutica, bioinformatica e bioingegneria.
Università di Pisa image

image Evento
image Impresa
vedi tutti

G-FORCE

An innovative program custom designed for researchers and young experts with a high technical-scientific profile, that accelerates individual and team talent and enables growth, both entrepreneurially and scientifically. The G-Force program has a total duration of 9 months with an initial residential phase of intensive activities of 3 months and a non-residential phase the following 6 months, which include workshops, mentoring, coaching, recruitment aid, matching of potential industry partners, combined with logistic services, business services, concessionary agreements and incentives. Accommodation in Bologna at affiliated structures for up to 2 team members is included for the first three months of the program.

WELCOME KIT

  • Accommodation in Bologna
  • Laboratories
  • Instrumentation
  • Business assessment
  • Custom" G Force "program

Mentors

Previous Next

Portfolio

BCI is a biotechnological startup focused on maximizing the biocompatibility of cardiac valve substitutes manufactured with animal tissues improving their performance and doubling the duration of operation over time.

sito web

Adam’s Hand is a myoelectric hand prosthesis, based on a patent-pending mechanism that allows to move all the fingers with just one motor, making them automatically adapt to the grasped object shape and dimension.

sito web

Complexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in a cancer patient. In addition to precision medicine, the platform can be used for the research and development of new drugs and the repositioning of older ones.

sito web

Diamante (Nano-Technologies for Autoimmune Disease Diagnosis) is an innovative startup with a strong social focus, led by a female team, specializing in the production of nanoparticles for the diagnosis of autoimmune diseases using biotech technologies based on the exploitation of plants as high value-added compounds.

sito web

eVai is the cloud platform of enGenome, developed to support medical geneticists in the diagnosis of hereditary diseases using NGS data analysis. Using Artificial Intelligence, eVAI provides the most accurate interpretation of genomic mutations.

sito web

Genoa Instruments is a spin-off of the Istituto Italiano di Tecnologia pioneering new technologies in the field of super-resolution optical microscopy, making them accessible for public and private research as well as for the industrial sector.

sito web

P4P S.r.L. produces innovative polymeric biomaterials processed with additive manufacturing techniques for the use of advanced drug delivery systems, improving and personalizing patient therapy.

Holey has created an integrated solution capable of producing custom-made orthopedic braces, for the fabrication of 3D printable orthotics, which can replace traditional plaster casts and commercial braces.

RELIEF S.r.L. proposes to engineer and bring to market a highly innovative device to combat severe urinary incontinence, providing a minimally invasive intraurethral insertion, activated with a small magnet.

MgShell is developing an intraocular drug delivery system for the treatment of maculopathy capable of releasing the right dose for the entire treatment, reducing the therapeutic load to a single injection.

Team

Ing. Antonio Danieli

Director General and Board Member
@ Fondazione Golinelli
CEO @ G-Factor Incubator-Accelerator

Dott.ssa Cristiana Vignoli

Director @ G-Factor Incubator-Accelerator

c.vignoli@fondazionegolinelli.it
Ing. Pietro Ferraris

Head of G-Factor Acceleration Program

p.ferraris@fondazionegolinelli.it
Dott.ssa Silvia Cozzi

Project Manager, G-Factor

s.cozzi@fondazionegolinelli.it
Elena Galli

Tutor and Startup Facilitator

e.galli@fondazionegolinelli.it
Fabio Bersani

Junior Project Manager

f.bersani@fondazionegolinelli.it

Subscribe to our newsletter

Be the first to get news and updates on our programs and events

Contact Us

How can we help you?